Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provide written informed consent and aged between 18 and 65 years of age.
Meets DSM-IV-TR criteria for a primary diagnosis of schizophrenia, had a PANSS total score ≥ 70 and ≤ 120 at Screening and Baseline, and a score ≥ 4 on the CGI-S at Screening and Baseline.
Not pregnant, if of reproductive potential agrees to use adequate and reliable contraception for duration of study.
Able and agrees to remain off prior antipsychotic medication for the duration of study.
Willing and able to comply with the protocol, including the inpatient requirements and outpatient visits.
You may not be if
Considered by the investigator to be at imminent risk of suicide or injury to self, others or property.
Any chronic organic disease of the CNS(other than schizophrenia)
Subjects are participating or participated in other clinical studies including marketed drugs or medical devices within 30 days before signing the informed consent form.
Clinically significant or history of alcohol abuse/alcoholism or drug abuse/dependence within the last 6 months.
